cufence 200 mg
mbi pharma ltd., israel - trientine as dihydrochloride - hard capsule - trientine as dihydrochloride 200 mg - trientine - cufence is indicated for the treatment of wilson’s disease in patients intolerant to d-penicillamine therapy, in adults, adolescents and children aged 5 years or older.
trientine 167 mg hard capsules
tillomed pharma gmbh - trientine dihydrochloride - capsule, hard - trientine
trientine raz 250 mg
raz pharmaceutics ltd, israel - trientine dihydrochloride - capsules - trientine dihydrochloride 250 mg - trientine - for the treatment of wilson’s disease in patient's intolerant of d-penicillaminetherapy, in adults, adolescents and children aged 5 years or older.
trientine 200mg capsules
special order - trientine dihydrochloride - oral capsule - 200mg
trientine 200mg capsules
univar solutions b.v. - trientine dihydrochloride - oral capsule - 200mg
metalite 250mg capsules
imported (japan) - trientine dihydrochloride - oral capsule - 250mg
mar-trientine capsule
marcan pharmaceuticals inc - trientine hydrochloride - capsule - 250mg - trientine hydrochloride 250mg - heavy metal antagonists
trientine hcl medomie 250 mg capsules
medomie pharma ltd, israel - trientine hydrochloride - hard capsule - trientine hydrochloride 250 mg - trientine - trientine medomie is indicated for the treatment of wilson’s disease in patients intolerant to d-penicillamine therapy, in adults, adolescents and children aged 5 years or older.
cuprior film-coated tablet
orphalan, france - trientine tetrahydrochloride - film-coated tablet - 150 mg
trientine dihydrochloride capsule, hard
navinta llc, united states - trientine dihydrochloride - capsule, hard - 250 mg,